LadRx (LADX) Stock Price

LadRx Price

Frankfurt·CLOSED
0.00
​
Market closed

LadRx stock price

Access this data via the Eulerpool API

LadRx business model & stock analysis

CytRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. The company is headquartered in Los Angeles, California and currently employs 4 full-time employees. The firm is focused on the clinical development of aldoxorubicin, its modified version of the chemotherapeutic agent, doxorubicin. The company is engaged in Phase III trials for aldoxorubicin as a therapy for patients with soft tissue sarcoma (STS) whose tumors have progressed after treatment with chemotherapy. The company is also involved in evaluating aldoxorubicin in a Phase IIb clinical trial in small cell lung cancer; a Phase II clinical trial in human immunodeficiency virus-related Kaposi's sarcoma; a Phase II clinical trial in patients with late-stage glioblastoma (brain cancer); a Phase Ib trial in combination with ifosfamide in patients with STS, and a Phase Ib trial in combination with gemcitabine in subjects with metastatic solid tumors. The company is engaged in the pre-clinical development for DK049, an anti-cancer drug conjugate that utilizes its Linker Activated Drug Release (LADR) technology.

Frequently asked questions about LadRx

7 analysts currently rate the LadRx stock: 6 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the LadRx share trades at 0.00 EUR (0.00 USD).

The LadRx share (LADX) is listed on 4 stock exchanges, including: London (0I5R.L), Frankfurt (CX5P.F), München (CX5P.MU).

The revenue cannot currently be calculated for LadRx.

The profit cannot currently be calculated for LadRx.

The P/E ratio cannot be calculated for LadRx at the moment.

The P/S cannot be calculated for LadRx currently.

The Eulerpool Quality Score for LadRx is 2/10.

The ISIN of LadRx is US2328287071. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of LadRx is A2H6Z0. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of LadRx is LADX. The ticker symbol is used to trade LadRx shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website cytrx.com
Currency
USD
Initial public offering
Nov 10, 1986
ISIN
US2328287071
Cusip
232828608
Sedol
BYWRVJ2
Market capitalization
100.00 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
0.42
P/B Ratio
0.00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
111.99 %
Last updated Oct 9, 2026, 1:25 AM

LadRx Peer Group

LadRx Ticker

FRANKFURT · CX5P.FLONDON · 0I5R.LMUNICH · CX5P.MUOTC · CYTR

All fundamentals and in-depth analysis of LadRx

Our stock analysis for LadRx stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of LadRx. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.